ONTOLOGY REPORT - ANNOTATIONS
| Term: | streptozocin |
|
| Accession: | CHEBI:9288
|
browse the term
|
| Definition: | An antibiotic that is produced by Streptomyces achromogenes. It is used as an antineoplastic agent and to induce diabetes in experimental animals. |
| Synonyms: | exact_synonym: | 2-deoxy-2-{[methyl(nitroso)carbamoyl]amino}-alpha-D-glucopyranose |
| | related_synonym: | 2-Deoxy-2-(((methylnitrosoamino)carbonyl)amino)-D-glucopyranose; 2-Deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose; C8H15N3O7; CN(N=O)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O; InChI=1S/C8H15N3O7/c1-11(10-17)8(16)9-4-6(14)5(13)3(2-12)18-7(4)15/h3-7,12-15H,2H2,1H3,(H,9,16)/t3-,4-,5-,6-,7+/m1/s1; InChIKey=ZSJLQEPLLKMAKR-GKHCUFPYSA-N; N-D-Glucosyl-(2)-N'-nitrosomethylharnstoff; N-D-Glucosyl-(2)-N'-nitrosomethylurea; Streptozocinium; Streptozotocin; estreptozocina; streptozocine; streptozocinum |
| | xref_casrn: | 18883-66-4 |
| | xref: | Beilstein:2060675 "Beilstein Registry Number"; ChemIDplus:18883-66-4 "CAS Registry Number"; CiteXplore:2954873 "PubMed citation"; DrugBank:DB00428 "DrugBank"; KEGG COMPOUND:18883-66-4 "CAS Registry Number"; KEGG COMPOUND:C07313 "KEGG COMPOUND"; KEGG DRUG:D05932 "KEGG DRUG" |
| | xref_mesh: | MESH:D013311 |
| | xref: | Patent:FR1434920 "Patent"; Wikipedia:Streptozocin "Wikipedia" |
|
|
streptozocin
|
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
increases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcb4 |
ATP-binding cassette, subfamily B (MDR/TAP), member 4 |
|
increases expression |
EXP |
4 |
21,946,274 |
22,004,328 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
multiple interactions |
EXP |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
decreases expression |
EXP |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
decreases activity |
EXP |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acadm |
acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
multiple interactions |
EXP |
2 |
251,866,645 |
251,890,729 |
RGD:6480464 |
CTD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
increases expression |
EXP |
10 |
95,361,338 |
95,381,455 |
RGD:6480464 |
CTD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
multiple interactions |
EXP |
10 |
95,361,338 |
95,381,455 |
RGD:6480464 |
CTD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
increases expression |
EXP |
10 |
95,361,338 |
95,381,455 |
RGD:6480464 |
CTD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
increases expression |
EXP |
10 |
95,361,338 |
95,381,455 |
RGD:6480464 |
CTD |
| G |
Ace2 |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 |
|
decreases expression |
ISO |
X |
51,051,758 |
51,096,036 |
RGD:6480464 |
CTD |
| G |
Ace2 |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 |
|
multiple interactions |
ISO |
X |
51,051,758 |
51,096,036 |
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
increases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
increases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
increases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
increases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
increases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Acmsd |
aminocarboxymuconate semialdehyde decarboxylase |
|
increases activity |
EXP |
13 |
40,547,366 |
40,573,698 |
RGD:6480464 |
CTD |
| G |
Acmsd |
aminocarboxymuconate semialdehyde decarboxylase |
|
increases expression |
EXP |
13 |
40,547,366 |
40,573,698 |
RGD:6480464 |
CTD |
| G |
Actc1 |
actin, alpha, cardiac muscle 1 |
|
decreases expression |
EXP |
3 |
99,901,022 |
99,906,558 |
RGD:6480464 |
CTD |
| G |
Actn4 |
actinin alpha 4 |
|
increases expression |
EXP |
1 |
84,000,723 |
84,073,767 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
decreases expression |
EXP |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipor1 |
adiponectin receptor 1 |
|
decreases expression |
EXP |
13 |
47,358,625 |
47,379,565 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenoceptor alpha 1A |
|
increases expression |
EXP |
15 |
46,173,429 |
46,263,198 |
RGD:6480464 |
CTD |
| G |
Adra1b |
adrenoceptor alpha 1B |
|
increases expression |
EXP |
10 |
28,889,092 |
28,946,889 |
RGD:6480464 |
CTD |
| G |
Adra1d |
adrenoceptor alpha 1D |
|
decreases expression |
EXP |
3 |
119,279,974 |
119,295,985 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
multiple interactions |
EXP |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
decreases expression |
EXP |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
increases expression |
EXP |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
EXP |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
multiple interactions |
EXP |
16 |
69,163,620 |
69,166,384 |
RGD:6480464 |
CTD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
increases expression |
EXP |
16 |
69,163,620 |
69,166,384 |
RGD:6480464 |
CTD |
| G |
Agrp |
agouti related protein homolog (mouse) |
|
multiple interactions |
EXP |
19 |
35,386,682 |
35,388,274 |
RGD:6480464 |
CTD |
| G |
Agrp |
agouti related protein homolog (mouse) |
|
increases expression |
EXP |
19 |
35,386,682 |
35,388,274 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
increases expression |
ISO |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
multiple interactions |
ISO |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
increases expression |
ISO |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
increases expression |
ISO |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
increases expression |
ISO |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Agtr2 |
angiotensin II receptor, type 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Agtr2 |
angiotensin II receptor, type 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Agtr2 |
angiotensin II receptor, type 2 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Agxt2 |
alanine-glyoxylate aminotransferase 2 |
|
multiple interactions |
EXP |
2 |
59,713,365 |
59,754,876 |
RGD:6480464 |
CTD |
| G |
Akr1a1 |
aldo-keto reductase family 1, member A1 (aldehyde reductase) |
|
increases expression |
EXP |
5 |
136,920,561 |
136,937,422 |
RGD:6480464 |
CTD |
| G |
Akr1b1 |
aldo-keto reductase family 1, member B1 (aldose reductase) |
|
multiple interactions |
ISO |
4 |
61,645,438 |
61,659,530 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases expression |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Alad |
aminolevulinate dehydratase |
|
multiple interactions |
ISO |
5 |
79,505,645 |
79,515,983 |
RGD:6480464 |
CTD |
| G |
Alas1 |
aminolevulinate, delta-, synthase 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Alas1 |
aminolevulinate, delta-, synthase 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
multiple interactions |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
increases secretion |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
multiple interactions |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
decreases expression |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
increases expression |
EXP |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldob |
aldolase B, fructose-bisphosphate |
|
increases expression |
EXP |
5 |
66,283,165 |
66,296,171 |
RGD:6480464 |
CTD |
| G |
Aldob |
aldolase B, fructose-bisphosphate |
|
multiple interactions |
EXP |
5 |
66,283,165 |
66,296,171 |
RGD:6480464 |
CTD |
| G |
Angpt1 |
angiopoietin 1 |
|
increases expression |
EXP |
7 |
78,195,504 |
78,451,471 |
RGD:6480464 |
CTD |
| G |
Angpt1 |
angiopoietin 1 |
|
decreases expression |
EXP |
7 |
78,195,504 |
78,451,471 |
RGD:6480464 |
CTD |
| G |
Angpt2 |
angiopoietin 2 |
|
increases expression |
EXP |
16 |
75,891,757 |
75,942,255 |
RGD:6480464 |
CTD |
| G |
Angpt2 |
angiopoietin 2 |
|
multiple interactions |
EXP |
16 |
75,891,757 |
75,942,255 |
RGD:6480464 |
CTD |
| G |
Angpt2 |
angiopoietin 2 |
|
multiple interactions |
EXP |
16 |
75,891,757 |
75,942,255 |
RGD:6480464 |
CTD |
| G |
Angpt2 |
angiopoietin 2 |
|
increases expression |
EXP |
16 |
75,891,757 |
75,942,255 |
RGD:6480464 |
CTD |
| G |
Angpt2 |
angiopoietin 2 |
|
increases expression |
EXP |
16 |
75,891,757 |
75,942,255 |
RGD:6480464 |
CTD |
| G |
Angpt2 |
angiopoietin 2 |
|
increases expression |
EXP |
16 |
75,891,757 |
75,942,255 |
RGD:6480464 |
CTD |
| G |
Angpt2 |
angiopoietin 2 |
|
increases expression |
EXP |
16 |
75,891,757 |
75,942,255 |
RGD:6480464 |
CTD |
| G |
Ankrd1 |
ankyrin repeat domain 1 |
|
increases expression |
EXP |
1 |
240,316,123 |
240,324,804 |
RGD:6480464 |
CTD |
| G |
Ankrd1 |
ankyrin repeat domain 1 |
|
multiple interactions |
EXP |
1 |
240,316,123 |
240,324,804 |
RGD:6480464 |
CTD |
| G |
Anpep |
alanyl (membrane) aminopeptidase |
|
decreases expression |
EXP |
1 |
135,600,751 |
135,619,208 |
RGD:6480464 |
CTD |
| G |
Anpep |
alanyl (membrane) aminopeptidase |
|
multiple interactions |
EXP |
1 |
135,600,751 |
135,619,208 |
RGD:6480464 |
CTD |
| G |
Anxa3 |
annexin A3 |
|
multiple interactions |
EXP |
14 |
14,245,112 |
14,297,100 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
multiple interactions |
EXP |
2 |
122,949,210 |
122,979,757 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
multiple interactions |
EXP |
2 |
122,949,210 |
122,979,757 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
increases expression |
EXP |
2 |
122,949,210 |
122,979,757 |
RGD:6480464 |
CTD |
| G |
Apex1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
increases response to substance |
ISO |
15 |
26,904,124 |
26,906,224 |
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
increases expression |
EXP |
1 |
79,003,634 |
79,006,387 |
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
multiple interactions |
EXP |
1 |
79,003,634 |
79,006,387 |
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
multiple interactions |
ISO |
1 |
79,003,634 |
79,006,387 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
EXP |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
increases expression |
EXP |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
Aqp1 |
aquaporin 1 |
|
decreases expression |
EXP |
4 |
84,098,346 |
84,110,524 |
RGD:6480464 |
CTD |
| G |
Aqp7 |
aquaporin 7 |
|
increases expression |
EXP |
5 |
58,433,731 |
58,447,853 |
RGD:6480464 |
CTD |
| G |
Aqp7 |
aquaporin 7 |
|
multiple interactions |
EXP |
5 |
58,433,731 |
58,447,853 |
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
decreases activity |
EXP |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Atp5a1 |
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle |
|
increases expression |
EXP |
18 |
74,735,267 |
74,743,088 |
RGD:6480464 |
CTD |
| G |
Atp5a1 |
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle |
|
multiple interactions |
EXP |
18 |
74,735,267 |
74,743,088 |
RGD:6480464 |
CTD |
| G |
Atp5b |
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
|
increases expression |
EXP |
7 |
1,376,552 |
1,383,228 |
RGD:6480464 |
CTD |
| G |
Atp5b |
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
|
multiple interactions |
EXP |
7 |
1,376,552 |
1,383,228 |
RGD:6480464 |
CTD |
| G |
Atp5j2 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2 |
|
affects expression |
ISO |
12 |
9,735,171 |
9,741,496 |
RGD:6480464 |
CTD |
| G |
Atp5j2 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2 |
|
increases expression |
EXP |
12 |
9,735,171 |
9,741,496 |
RGD:6480464 |
CTD |
| G |
Atp5j2 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2 |
|
multiple interactions |
EXP |
12 |
9,735,171 |
9,741,496 |
RGD:6480464 |
CTD |
| G |
Atp5o |
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit |
|
increases expression |
EXP |
11 |
31,914,320 |
31,920,632 |
RGD:6480464 |
CTD |
| G |
Atp5o |
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit |
|
multiple interactions |
EXP |
11 |
31,914,320 |
31,920,632 |
RGD:6480464 |
CTD |
| G |
Atp6ap2 |
ATPase, H+ transporting, lysosomal accessory protein 2 |
|
multiple interactions |
EXP |
X |
22,264,078 |
22,291,988 |
RGD:6480464 |
CTD |
| G |
Atp6ap2 |
ATPase, H+ transporting, lysosomal accessory protein 2 |
|
increases expression |
EXP |
X |
22,264,078 |
22,291,988 |
RGD:6480464 |
CTD |
| G |
Axl |
Axl receptor tyrosine kinase |
|
increases expression |
EXP |
1 |
80,964,751 |
80,994,300 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
decreases expression |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
increases expression |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bckdha |
branched chain ketoacid dehydrogenase E1, alpha polypeptide |
|
affects expression |
ISO |
1 |
80,837,906 |
80,866,672 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bdkrb1 |
bradykinin receptor B1 |
|
multiple interactions |
EXP |
6 |
129,760,129 |
129,762,545 |
RGD:6480464 |
CTD |
| G |
Bdkrb1 |
bradykinin receptor B1 |
|
increases expression |
ISO |
6 |
129,760,129 |
129,762,545 |
RGD:6480464 |
CTD |
| G |
Bdkrb2 |
bradykinin receptor B2 |
|
multiple interactions |
EXP |
6 |
129,744,781 |
129,748,851 |
RGD:6480464 |
CTD |
| G |
Bdkrb2 |
bradykinin receptor B2 |
|
increases expression |
ISO |
6 |
129,744,781 |
129,748,851 |
RGD:6480464 |
CTD |
| G |
Bhmt |
betaine-homocysteine S-methyltransferase |
|
increases activity |
EXP |
2 |
23,923,651 |
23,943,320 |
RGD:6480464 |
CTD |
| G |
Bhmt |
betaine-homocysteine S-methyltransferase |
|
increases expression |
EXP |
2 |
23,923,651 |
23,943,320 |
RGD:6480464 |
CTD |
| G |
Bmp7 |
bone morphogenetic protein 7 |
|
increases expression |
EXP |
3 |
163,723,429 |
163,799,567 |
RGD:6480464 |
CTD |
| G |
Bmp7 |
bone morphogenetic protein 7 |
|
affects expression |
EXP |
3 |
163,723,429 |
163,799,567 |
RGD:6480464 |
CTD |
| G |
C1qb |
complement component 1, q subcomponent, B chain |
|
increases expression |
EXP |
5 |
155,647,524 |
155,653,074 |
RGD:6480464 |
CTD |
| G |
C1qb |
complement component 1, q subcomponent, B chain |
|
multiple interactions |
EXP |
5 |
155,647,524 |
155,653,074 |
RGD:6480464 |
CTD |
| G |
C4b |
complement component 4B (Chido blood group) |
|
increases expression |
EXP |
20 |
4,300,687 |
4,315,882 |
RGD:6480464 |
CTD |
| G |
C4b |
complement component 4B (Chido blood group) |
|
multiple interactions |
EXP |
20 |
4,300,687 |
4,315,882 |
RGD:6480464 |
CTD |
| G |
Calm3 |
calmodulin 3 |
|
decreases expression |
EXP |
1 |
77,245,609 |
77,252,717 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
decreases expression |
EXP |
19 |
24,964,775 |
24,969,670 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
multiple interactions |
EXP |
19 |
24,964,775 |
24,969,670 |
RGD:6480464 |
CTD |
| G |
Cartpt |
CART prepropeptide |
|
decreases expression |
EXP |
2 |
30,889,817 |
30,891,837 |
RGD:6480464 |
CTD |
| G |
Cartpt |
CART prepropeptide |
|
multiple interactions |
EXP |
2 |
30,889,817 |
30,891,837 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp6 |
caspase 6 |
|
increases expression |
EXP |
2 |
227,361,538 |
227,373,844 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
increases expression |
EXP |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cbr1 |
carbonyl reductase 1 |
|
decreases activity |
EXP |
11 |
33,787,957 |
33,790,320 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
affects response to substance |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Cd80 |
Cd80 molecule |
|
multiple interactions |
ISO |
11 |
64,045,358 |
64,070,072 |
RGD:6480464 |
CTD |
| G |
Cd80 |
Cd80 molecule |
|
increases expression |
ISO |
11 |
64,045,358 |
64,070,072 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
multiple interactions |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
increases expression |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Chat |
choline O-acetyltransferase |
|
multiple interactions |
EXP |
16 |
7,913,026 |
7,965,985 |
RGD:6480464 |
CTD |
| G |
Chat |
choline O-acetyltransferase |
|
affects localization |
EXP |
16 |
7,913,026 |
7,965,985 |
RGD:6480464 |
CTD |
| G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
|
multiple interactions |
EXP |
4 |
63,911,292 |
63,913,354 |
RGD:6480464 |
CTD |
| G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
|
multiple interactions |
EXP |
4 |
63,911,292 |
63,913,354 |
RGD:6480464 |
CTD |
| G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
|
affects expression |
EXP |
4 |
63,911,292 |
63,913,354 |
RGD:6480464 |
CTD |
| G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
|
increases expression |
EXP |
4 |
63,911,292 |
63,913,354 |
RGD:6480464 |
CTD |
| G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
|
multiple interactions |
EXP |
17 |
71,214,906 |
71,218,463 |
RGD:6480464 |
CTD |
| G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
|
affects expression |
EXP |
17 |
71,214,906 |
71,218,463 |
RGD:6480464 |
CTD |
| G |
Cisd1 |
CDGSH iron sulfur domain 1 |
|
increases expression |
EXP |
20 |
17,985,985 |
17,999,366 |
RGD:6480464 |
CTD |
| G |
Cisd1 |
CDGSH iron sulfur domain 1 |
|
multiple interactions |
EXP |
20 |
17,985,985 |
17,999,366 |
RGD:6480464 |
CTD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
increases expression |
EXP |
1 |
12,721,500 |
12,723,943 |
RGD:6480464 |
CTD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
multiple interactions |
EXP |
1 |
12,721,500 |
12,723,943 |
RGD:6480464 |
CTD |
| G |
Ckmt2 |
creatine kinase, mitochondrial 2, sarcomeric |
|
multiple interactions |
EXP |
2 |
22,084,948 |
22,106,014 |
RGD:6480464 |
CTD |
| G |
Ckmt2 |
creatine kinase, mitochondrial 2, sarcomeric |
|
decreases expression |
EXP |
2 |
22,084,948 |
22,106,014 |
RGD:6480464 |
CTD |
| G |
Clic4 |
chloride intracellular channel 4 |
|
affects expression |
ISO |
5 |
154,005,244 |
154,066,883 |
RGD:6480464 |
CTD |
| G |
Clpp |
ClpP caseinolytic peptidase, ATP-dependent, proteolytic subunit homolog (E. coli) |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Col4a1 |
collagen, type IV, alpha 1 |
|
decreases expression |
ISO |
16 |
83,045,183 |
83,157,835 |
RGD:6480464 |
CTD |
| G |
Col4a1 |
collagen, type IV, alpha 1 |
|
increases expression |
ISO |
16 |
83,045,183 |
83,157,835 |
RGD:6480464 |
CTD |
| G |
Cox17 |
cytochrome c oxidase assembly homolog 17 (yeast) |
|
affects expression |
ISO |
11 |
64,183,573 |
64,185,985 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
increases expression |
EXP |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
multiple interactions |
EXP |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Csrp3 |
cysteine and glycine-rich protein 3 (cardiac LIM protein) |
|
increases expression |
EXP |
1 |
98,601,681 |
98,611,747 |
RGD:6480464 |
CTD |
| G |
Csrp3 |
cysteine and glycine-rich protein 3 (cardiac LIM protein) |
|
multiple interactions |
EXP |
1 |
98,601,681 |
98,611,747 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
ISO |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
multiple interactions |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
multiple interactions |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
multiple interactions |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
multiple interactions |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctss |
cathepsin S |
|
increases expression |
EXP |
2 |
190,425,290 |
190,466,877 |
RGD:6480464 |
CTD |
| G |
Ctss |
cathepsin S |
|
multiple interactions |
EXP |
2 |
190,425,290 |
190,466,877 |
RGD:6480464 |
CTD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
multiple interactions |
EXP |
19 |
52,713,150 |
52,721,609 |
RGD:6480464 |
CTD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
increases expression |
EXP |
19 |
52,713,150 |
52,721,609 |
RGD:6480464 |
CTD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
multiple interactions |
EXP |
19 |
52,713,150 |
52,721,609 |
RGD:6480464 |
CTD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
increases expression |
EXP |
19 |
52,713,150 |
52,721,609 |
RGD:6480464 |
CTD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
increases expression |
EXP |
19 |
52,713,150 |
52,721,609 |
RGD:6480464 |
CTD |
| G |
Cybb |
cytochrome b-245, beta polypeptide |
|
increases expression |
ISO |
X |
25,514,572 |
25,547,181 |
RGD:6480464 |
CTD |
| G |
Cybb |
cytochrome b-245, beta polypeptide |
|
multiple interactions |
ISO |
X |
25,514,572 |
25,547,181 |
RGD:6480464 |
CTD |
| G |
Cybb |
cytochrome b-245, beta polypeptide |
|
increases expression |
EXP |
X |
25,514,572 |
25,547,181 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
multiple interactions |
EXP |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
affects localization |
EXP |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
affects localization |
EXP |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
increases expression |
EXP |
7 |
113,043,365 |
113,049,779 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases expression |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases expression |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Cyp8b1 |
cytochrome P450, family 8, subfamily b, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
127,018,908 |
127,020,878 |
RGD:6480464 |
CTD |
| G |
Cyp8b1 |
cytochrome P450, family 8, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
8 |
127,018,908 |
127,020,878 |
RGD:6480464 |
CTD |
| G |
Dao |
D-amino-acid oxidase |
|
increases expression |
EXP |
12 |
43,627,593 |
43,648,332 |
RGD:6480464 |
CTD |
| G |
Dbt |
dihydrolipoamide branched chain transacylase E2 |
|
affects expression |
ISO |
2 |
212,759,312 |
212,788,180 |
RGD:6480464 |
CTD |
| G |
Decr1 |
2,4-dienoyl CoA reductase 1, mitochondrial |
|
increases expression |
EXP |
5 |
30,492,196 |
30,520,172 |
RGD:6480464 |
CTD |
| G |
Decr1 |
2,4-dienoyl CoA reductase 1, mitochondrial |
|
multiple interactions |
EXP |
5 |
30,492,196 |
30,520,172 |
RGD:6480464 |
CTD |
| G |
Des |
desmin |
|
multiple interactions |
EXP |
9 |
74,637,783 |
74,645,499 |
RGD:6480464 |
CTD |
| G |
Des |
desmin |
|
increases expression |
EXP |
9 |
74,637,783 |
74,645,499 |
RGD:6480464 |
CTD |
| G |
Des |
desmin |
|
increases expression |
EXP |
9 |
74,637,783 |
74,645,499 |
RGD:6480464 |
CTD |
| G |
Dlat |
dihydrolipoamide S-acetyltransferase |
|
multiple interactions |
EXP |
8 |
53,989,491 |
54,014,779 |
RGD:6480464 |
CTD |
| G |
Dlat |
dihydrolipoamide S-acetyltransferase |
|
increases expression |
EXP |
8 |
53,989,491 |
54,014,779 |
RGD:6480464 |
CTD |
| G |
Dld |
dihydrolipoamide dehydrogenase |
|
increases expression |
EXP |
6 |
49,185,188 |
49,205,894 |
RGD:6480464 |
CTD |
| G |
Dld |
dihydrolipoamide dehydrogenase |
|
multiple interactions |
EXP |
6 |
49,185,188 |
49,205,894 |
RGD:6480464 |
CTD |
| G |
Dlst |
dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) |
|
multiple interactions |
EXP |
6 |
109,156,751 |
109,180,537 |
RGD:6480464 |
CTD |
| G |
Dlst |
dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) |
|
increases expression |
EXP |
6 |
109,156,751 |
109,180,537 |
RGD:6480464 |
CTD |
| G |
Dpp4 |
dipeptidylpeptidase 4 |
|
increases response to substance |
EXP |
3 |
44,279,255 |
44,360,283 |
RGD:6480464 |
CTD |
| G |
Dpp4 |
dipeptidylpeptidase 4 |
|
decreases activity |
EXP |
3 |
44,279,255 |
44,360,283 |
RGD:6480464 |
CTD |
| G |
Dpp4 |
dipeptidylpeptidase 4 |
|
decreases expression |
EXP |
3 |
44,279,255 |
44,360,283 |
RGD:6480464 |
CTD |
| G |
Dpp4 |
dipeptidylpeptidase 4 |
|
increases expression |
EXP |
3 |
44,279,255 |
44,360,283 |
RGD:6480464 |
CTD |
| G |
Echs1 |
enoyl CoA hydratase, short chain, 1, mitochondrial |
|
increases expression |
EXP |
1 |
199,901,585 |
199,910,412 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
increases expression |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
multiple interactions |
EXP |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
increases expression |
EXP |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Elk1 |
ELK1, member of ETS oncogene family |
|
increases phosphorylation |
EXP |
X |
12,597,863 |
12,604,248 |
RGD:6480464 |
CTD |
| G |
Eno1-ps1 |
enolase 1, (alpha), pseudogene 1 |
|
decreases expression |
EXP |
3 |
55,187,532 |
55,203,020 |
RGD:6480464 |
CTD |
| G |
Eno1-ps1 |
enolase 1, (alpha), pseudogene 1 |
|
multiple interactions |
EXP |
3 |
55,187,532 |
55,203,020 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
multiple interactions |
EXP |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
multiple interactions |
EXP |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
decreases expression |
EXP |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
increases expression |
EXP |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
increases expression |
EXP |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Epor |
erythropoietin receptor |
|
multiple interactions |
EXP |
8 |
21,061,310 |
21,065,886 |
RGD:6480464 |
CTD |
| G |
Epor |
erythropoietin receptor |
|
multiple interactions |
EXP |
8 |
21,061,310 |
21,065,886 |
RGD:6480464 |
CTD |
| G |
Epor |
erythropoietin receptor |
|
decreases expression |
EXP |
8 |
21,061,310 |
21,065,886 |
RGD:6480464 |
CTD |
| G |
Epor |
erythropoietin receptor |
|
increases expression |
EXP |
8 |
21,061,310 |
21,065,886 |
RGD:6480464 |
CTD |
| G |
Epor |
erythropoietin receptor |
|
increases expression |
EXP |
8 |
21,061,310 |
21,065,886 |
RGD:6480464 |
CTD |
| G |
Epor |
erythropoietin receptor |
|
increases expression |
EXP |
8 |
21,061,310 |
21,065,886 |
RGD:6480464 |
CTD |
| G |
Etfdh |
electron-transferring-flavoprotein dehydrogenase |
|
affects expression |
ISO |
2 |
171,008,641 |
171,030,692 |
RGD:6480464 |
CTD |
| G |
Fars2 |
phenylalanyl-tRNA synthetase 2, mitochondrial |
|
affects expression |
ISO |
17 |
34,595,255 |
35,048,596 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
EXP |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
increases expression |
EXP |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fh |
fumarate hydratase |
|
affects expression |
ISO |
13 |
91,329,837 |
91,355,722 |
RGD:6480464 |
CTD |
| G |
Flt1 |
FMS-related tyrosine kinase 1 |
|
multiple interactions |
EXP |
12 |
7,858,092 |
8,035,966 |
RGD:6480464 |
CTD |
| G |
Flt1 |
FMS-related tyrosine kinase 1 |
|
increases expression |
EXP |
12 |
7,858,092 |
8,035,966 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Foxo3 |
forkhead box O3 |
|
decreases expression |
EXP |
20 |
46,171,784 |
46,262,818 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
multiple interactions |
EXP |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
increases expression |
EXP |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
multiple interactions |
EXP |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
multiple interactions |
EXP |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
decreases activity |
EXP |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
Gas6 |
growth arrest specific 6 |
|
increases expression |
EXP |
16 |
80,900,159 |
80,930,929 |
RGD:6480464 |
CTD |
| G |
Gbas |
glioblastoma amplified sequence |
|
affects expression |
ISO |
12 |
27,928,465 |
27,968,759 |
RGD:6480464 |
CTD |
| G |
Gcg |
glucagon |
|
multiple interactions |
EXP |
3 |
44,433,180 |
44,438,004 |
RGD:6480464 |
CTD |
| G |
Gcg |
glucagon |
|
decreases expression |
EXP |
3 |
44,433,180 |
44,438,004 |
RGD:6480464 |
CTD |
| G |
Gfm1 |
G elongation factor, mitochondrial 1 |
|
affects expression |
ISO |
2 |
157,283,046 |
157,327,969 |
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ghrl |
ghrelin/obestatin prepropeptide |
|
multiple interactions |
EXP |
4 |
149,622,566 |
149,628,111 |
RGD:6480464 |
CTD |
| G |
Gnmt |
glycine N-methyltransferase |
|
multiple interactions |
EXP |
9 |
10,127,092 |
10,130,444 |
RGD:6480464 |
CTD |
| G |
Gnmt |
glycine N-methyltransferase |
|
increases activity |
EXP |
9 |
10,127,092 |
10,130,444 |
RGD:6480464 |
CTD |
| G |
Gnmt |
glycine N-methyltransferase |
|
increases expression |
EXP |
9 |
10,127,092 |
10,130,444 |
RGD:6480464 |
CTD |
| G |
Got2 |
glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) |
|
multiple interactions |
EXP |
19 |
9,629,687 |
9,655,336 |
RGD:6480464 |
CTD |
| G |
Got2 |
glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) |
|
increases expression |
EXP |
19 |
9,629,687 |
9,655,336 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
increases expression |
EXP |
10 |
40,311,094 |
40,319,382 |
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
multiple interactions |
EXP |
10 |
40,311,094 |
40,319,382 |
RGD:6480464 |
CTD |
| G |
Grem1 |
gremlin 1 |
|
increases expression |
EXP |
3 |
99,597,201 |
99,608,935 |
RGD:6480464 |
CTD |
| G |
Grm5 |
glutamate receptor, metabotropic 5 |
|
increases expression |
EXP |
1 |
143,857,225 |
144,477,419 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases expression |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases phosphorylation |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
multiple interactions |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase alpha 3 |
|
increases expression |
EXP |
9 |
20,005,570 |
20,032,031 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase alpha 3 |
|
multiple interactions |
EXP |
9 |
20,005,570 |
20,032,031 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
increases expression |
EXP |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
increases expression |
EXP |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
multiple interactions |
EXP |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gulo |
gulonolactone (L-) oxidase |
|
multiple interactions |
EXP |
15 |
45,410,685 |
45,434,014 |
RGD:6480464 |
CTD |
| G |
Gulo |
gulonolactone (L-) oxidase |
|
decreases expression |
EXP |
15 |
45,410,685 |
45,434,014 |
RGD:6480464 |
CTD |
| G |
Gys2 |
glycogen synthase 2 |
|
multiple interactions |
EXP |
4 |
179,984,036 |
180,018,819 |
RGD:6480464 |
CTD |
| G |
Hao2 |
hydroxyacid oxidase 2 (long chain) |
|
multiple interactions |
EXP |
2 |
193,532,833 |
193,557,229 |
RGD:6480464 |
CTD |
| G |
Hao2 |
hydroxyacid oxidase 2 (long chain) |
|
decreases expression |
EXP |
2 |
193,532,833 |
193,557,229 |
RGD:6480464 |
CTD |
| G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
decreases expression |
ISO |
10 |
31,834,519 |
31,858,019 |
RGD:6480464 |
CTD |
| G |
Hba1 |
hemoglobin, alpha 1 |
|
multiple interactions |
EXP |
10 |
15,584,360 |
15,585,215 |
RGD:6480464 |
CTD |
| G |
Hba1 |
hemoglobin, alpha 1 |
|
increases glycation |
EXP |
10 |
15,584,360 |
15,585,215 |
RGD:6480464 |
CTD |
| G |
Hbb-b1 |
hemoglobin, beta adult major chain |
|
decreases expression |
EXP |
1 |
161,590,671 |
161,598,127 |
RGD:6480464 |
CTD |
| G |
Hbb-b1 |
hemoglobin, beta adult major chain |
|
multiple interactions |
EXP |
1 |
161,590,671 |
161,598,127 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
multiple interactions |
EXP |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
|
increases expression |
EXP |
2 |
193,128,736 |
193,143,106 |
RGD:6480464 |
CTD |
| G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
|
multiple interactions |
EXP |
2 |
193,128,736 |
193,143,106 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
decreases activity |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hsd17b10 |
hydroxysteroid (17-beta) dehydrogenase 10 |
|
decreases expression |
EXP |
X |
41,489,343 |
41,491,788 |
RGD:6480464 |
CTD |
| G |
Hsd17b10 |
hydroxysteroid (17-beta) dehydrogenase 10 |
|
multiple interactions |
EXP |
X |
41,489,343 |
41,491,788 |
RGD:6480464 |
CTD |
| G |
Hsd17b4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
|
affects expression |
ISO |
18 |
45,157,435 |
45,251,606 |
RGD:6480464 |
CTD |
| G |
Hspa2 |
heat shock protein 2 |
|
affects expression |
ISO |
6 |
99,000,541 |
99,003,041 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
multiple interactions |
EXP |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
|
multiple interactions |
EXP |
2 |
36,434,518 |
36,435,786 |
RGD:6480464 |
CTD |
| G |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
multiple interactions |
EXP |
15 |
55,463,743 |
55,532,293 |
RGD:6480464 |
CTD |
| G |
Iapp |
islet amyloid polypeptide |
|
multiple interactions |
EXP |
4 |
179,855,956 |
179,860,871 |
RGD:6480464 |
CTD |
| G |
Iapp |
islet amyloid polypeptide |
|
decreases expression |
EXP |
4 |
179,855,956 |
179,860,871 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Idh2 |
isocitrate dehydrogenase 2 (NADP+), mitochondrial |
|
affects expression |
ISO |
1 |
135,876,052 |
135,895,373 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases expression |
EXP |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
decreases expression |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
EXP |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
increases expression |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
multiple interactions |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Impa2 |
inositol (myo)-1(or 4)-monophosphatase 2 |
|
increases expression |
EXP |
18 |
63,809,336 |
63,840,069 |
RGD:6480464 |
CTD |
| G |
Impa2 |
inositol (myo)-1(or 4)-monophosphatase 2 |
|
multiple interactions |
EXP |
18 |
63,809,336 |
63,840,069 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
decreases secretion |
ISO |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
ISO |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
decreases secretion |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
decreases expression |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
decreases response to substance |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
ISO |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
decreases expression |
ISO |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
ISO |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
decreases secretion |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
increases expression |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
multiple interactions |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
multiple interactions |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
multiple interactions |
EXP |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
decreases expression |
EXP |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
multiple interactions |
EXP |
12 |
2,934,967 |
3,087,691 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
multiple interactions |
EXP |
12 |
2,934,967 |
3,087,691 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
affects expression |
EXP |
12 |
2,934,967 |
3,087,691 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
decreases expression |
EXP |
12 |
2,934,967 |
3,087,691 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
decreases phosphorylation |
EXP |
12 |
2,934,967 |
3,087,691 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
increases expression |
EXP |
12 |
2,934,967 |
3,087,691 |
RGD:6480464 |
CTD |
| G |
Itgal |
integrin, alpha L |
|
multiple interactions |
EXP |
1 |
186,561,795 |
186,598,908 |
RGD:6480464 |
CTD |
| G |
Itgal |
integrin, alpha L |
|
increases expression |
EXP |
1 |
186,561,795 |
186,598,908 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin, alpha M |
|
increases expression |
EXP |
1 |
187,334,413 |
187,385,583 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin, alpha M |
|
multiple interactions |
EXP |
1 |
187,334,413 |
187,385,583 |
RGD:6480464 |
CTD |
| G |
Itgb2 |
integrin, beta 2 |
|
multiple interactions |
EXP |
20 |
11,446,521 |
11,485,009 |
RGD:6480464 |
CTD |
| G |
Itgb2 |
integrin, beta 2 |
|
increases expression |
EXP |
20 |
11,446,521 |
11,485,009 |
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain receptor |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain receptor |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain receptor |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain receptor |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Kng1 |
kininogen 1 |
|
multiple interactions |
EXP |
11 |
80,109,499 |
80,131,887 |
RGD:6480464 |
CTD |
| G |
Kng1 |
kininogen 1 |
|
increases response to substance |
EXP |
11 |
80,109,499 |
80,131,887 |
RGD:6480464 |
CTD |
| G |
Lap3 |
leucine aminopeptidase 3 |
|
affects expression |
ISO |
14 |
70,680,077 |
70,699,061 |
RGD:6480464 |
CTD |
| G |
Lcat |
lecithin cholesterol acyltransferase |
|
multiple interactions |
EXP |
19 |
35,781,507 |
35,784,966 |
RGD:6480464 |
CTD |
| G |
Ldhb |
lactate dehydrogenase B |
|
increases expression |
EXP |
4 |
180,061,567 |
180,079,473 |
RGD:6480464 |
CTD |
| G |
Ldhb |
lactate dehydrogenase B |
|
multiple interactions |
EXP |
4 |
180,061,567 |
180,079,473 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
multiple interactions |
EXP |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
increases expression |
EXP |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
multiple interactions |
EXP |
1 |
80,663,791 |
80,682,480 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
increases expression |
EXP |
1 |
80,663,791 |
80,682,480 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
EXP |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lrp5 |
low density lipoprotein receptor-related protein 5 |
|
affects expression |
ISO |
1 |
206,102,750 |
206,206,350 |
RGD:6480464 |
CTD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
multiple interactions |
ISO |
1 |
15,205,361 |
15,346,422 |
RGD:6480464 |
CTD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
multiple interactions |
ISO |
1 |
15,205,361 |
15,346,422 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases activity |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases expression |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases expression |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
increases phosphorylation |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
EXP |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
increases phosphorylation |
EXP |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases activity |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases expression |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapkapk2 |
mitogen-activated protein kinase-activated protein kinase 2 |
|
multiple interactions |
ISO |
13 |
43,994,943 |
44,041,504 |
RGD:6480464 |
CTD |
| G |
Mapkapk2 |
mitogen-activated protein kinase-activated protein kinase 2 |
|
increases expression |
ISO |
13 |
43,994,943 |
44,041,504 |
RGD:6480464 |
CTD |
| G |
Mas1 |
MAS1 oncogene |
|
decreases expression |
ISO |
1 |
42,154,786 |
42,185,750 |
RGD:6480464 |
CTD |
| G |
Mas1 |
MAS1 oncogene |
|
multiple interactions |
ISO |
1 |
42,154,786 |
42,185,750 |
RGD:6480464 |
CTD |
| G |
Mdh1 |
malate dehydrogenase 1, NAD (soluble) |
|
multiple interactions |
EXP |
14 |
102,259,130 |
102,273,788 |
RGD:6480464 |
CTD |
| G |
Mdh2 |
malate dehydrogenase 2, NAD (mitochondrial) |
|
multiple interactions |
EXP |
12 |
22,021,302 |
22,034,257 |
RGD:6480464 |
CTD |
| G |
Mep1a |
meprin 1 alpha |
|
multiple interactions |
EXP |
9 |
13,170,762 |
13,201,094 |
RGD:6480464 |
CTD |
| G |
Mgea5 |
meningioma expressed antigen 5 (hyaluronidase) |
|
multiple interactions |
ISO |
1 |
250,966,386 |
251,000,363 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mme |
membrane metallo-endopeptidase |
|
multiple interactions |
EXP |
2 |
153,031,724 |
153,114,515 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
decreases expression |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
increases expression |
ISO |
8 |
4,315,601 |
4,329,146 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
multiple interactions |
ISO |
8 |
4,315,601 |
4,329,146 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
decreases expression |
EXP |
8 |
4,315,601 |
4,329,146 |
RGD:6480464 |
CTD |
| G |
Mmp7 |
matrix metallopeptidase 7 |
|
multiple interactions |
ISO |
8 |
4,526,018 |
4,533,730 |
RGD:6480464 |
CTD |
| G |
Mmp7 |
matrix metallopeptidase 7 |
|
increases expression |
ISO |
8 |
4,526,018 |
4,533,730 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mpz |
myelin protein zero |
|
multiple interactions |
EXP |
13 |
87,040,479 |
87,045,378 |
RGD:6480464 |
CTD |
| G |
Mpz |
myelin protein zero |
|
decreases expression |
EXP |
13 |
87,040,479 |
87,045,378 |
RGD:6480464 |
CTD |
| G |
Mrpl14 |
mitochondrial ribosomal protein L14 |
|
affects expression |
ISO |
9 |
10,901,822 |
10,907,253 |
RGD:6480464 |
CTD |
| G |
Mrpl18 |
mitochondrial ribosomal protein L18 |
|
affects expression |
ISO |
1 |
42,111,647 |
42,116,465 |
RGD:6480464 |
CTD |
| G |
Mrpl42 |
mitochondrial ribosomal protein L42 |
|
affects expression |
ISO |
7 |
32,683,441 |
32,707,184 |
RGD:6480464 |
CTD |
| G |
Mrps7 |
mitochondrial ribosomal protein S7 |
|
affects expression |
ISO |
10 |
105,683,558 |
105,687,212 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
|
decreases activity |
EXP |
17 |
68,782,708 |
68,867,101 |
RGD:6480464 |
CTD |
| G |
Myh3 |
myosin, heavy chain 3, skeletal muscle, embryonic |
|
increases expression |
EXP |
10 |
53,776,858 |
53,800,677 |
RGD:6480464 |
CTD |
| G |
Myh3 |
myosin, heavy chain 3, skeletal muscle, embryonic |
|
multiple interactions |
EXP |
10 |
53,776,858 |
53,800,677 |
RGD:6480464 |
CTD |
| G |
Myh6 |
myosin, heavy chain 6, cardiac muscle, alpha |
|
multiple interactions |
EXP |
15 |
33,044,506 |
33,068,098 |
RGD:6480464 |
CTD |
| G |
Myh6 |
myosin, heavy chain 6, cardiac muscle, alpha |
|
decreases expression |
EXP |
15 |
33,044,506 |
33,068,098 |
RGD:6480464 |
CTD |
| G |
Myh7 |
myosin, heavy chain 7, cardiac muscle, beta |
|
multiple interactions |
EXP |
15 |
33,072,928 |
33,094,595 |
RGD:6480464 |
CTD |
| G |
Myh7 |
myosin, heavy chain 7, cardiac muscle, beta |
|
increases expression |
EXP |
15 |
33,072,928 |
33,094,595 |
RGD:6480464 |
CTD |
| G |
Ncf2 |
neutrophil cytosolic factor 2 |
|
increases expression |
ISO |
13 |
67,806,516 |
67,834,105 |
RGD:6480464 |
CTD |
| G |
Ncf2 |
neutrophil cytosolic factor 2 |
|
multiple interactions |
ISO |
13 |
67,806,516 |
67,834,105 |
RGD:6480464 |
CTD |
| G |
Ndst1 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
|
multiple interactions |
EXP |
18 |
56,638,891 |
56,677,831 |
RGD:6480464 |
CTD |
| G |
Ndst1 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
|
decreases expression |
EXP |
18 |
56,638,891 |
56,677,831 |
RGD:6480464 |
CTD |
| G |
Ndufa8 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8 |
|
affects expression |
ISO |
3 |
15,146,311 |
15,159,529 |
RGD:6480464 |
CTD |
| G |
Ndufab1 |
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1 |
|
increases expression |
EXP |
1 |
180,908,331 |
180,921,734 |
RGD:6480464 |
CTD |
| G |
Ndufs2 |
NADH dehydrogenase (ubiquinone) Fe-S protein 2 |
|
multiple interactions |
EXP |
13 |
87,124,431 |
87,137,497 |
RGD:6480464 |
CTD |
| G |
Ndufs4 |
NADH dehydrogenase (ubiquinone) Fe-S protein 4 |
|
multiple interactions |
EXP |
2 |
45,839,236 |
46,479,619 |
RGD:6480464 |
CTD |
| G |
Ndufs4 |
NADH dehydrogenase (ubiquinone) Fe-S protein 4 |
|
increases expression |
EXP |
2 |
45,839,236 |
46,479,619 |
RGD:6480464 |
CTD |
| G |
Ndufv2 |
NADH dehydrogenase (ubiquinone) flavoprotein 2 |
|
multiple interactions |
EXP |
9 |
104,852,714 |
104,873,325 |
RGD:6480464 |
CTD |
| G |
Nes |
nestin |
|
multiple interactions |
ISO |
2 |
180,051,907 |
180,060,947 |
RGD:6480464 |
CTD |
| G |
Nes |
nestin |
|
decreases expression |
EXP |
2 |
180,051,907 |
180,060,947 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases activity |
EXP |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases activity |
EXP |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases expression |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases expression |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases phosphorylation |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
multiple interactions |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
multiple interactions |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
multiple interactions |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
affects localization |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
decreases expression |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
increases expression |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
decreases expression |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Nnt |
nicotinamide nucleotide transhydrogenase |
|
multiple interactions |
EXP |
2 |
51,496,456 |
51,589,901 |
RGD:6480464 |
CTD |
| G |
Nnt |
nicotinamide nucleotide transhydrogenase |
|
increases expression |
EXP |
2 |
51,496,456 |
51,589,901 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
EXP |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
decreases expression |
EXP |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases activity |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
decreases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
decreases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
decreases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
decreases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
decreases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nox4 |
NADPH oxidase 4 |
|
multiple interactions |
EXP |
1 |
143,415,816 |
143,603,554 |
RGD:6480464 |
CTD |
| G |
Nox4 |
NADPH oxidase 4 |
|
increases activity |
EXP |
1 |
143,415,816 |
143,603,554 |
RGD:6480464 |
CTD |
| G |
Nox4 |
NADPH oxidase 4 |
|
increases expression |
EXP |
1 |
143,415,816 |
143,603,554 |
RGD:6480464 |
CTD |
| G |
Nox4 |
NADPH oxidase 4 |
|
multiple interactions |
EXP |
1 |
143,415,816 |
143,603,554 |
RGD:6480464 |
CTD |
| G |
Nox4 |
NADPH oxidase 4 |
|
increases expression |
EXP |
1 |
143,415,816 |
143,603,554 |
RGD:6480464 |
CTD |
| G |
Nphs1 |
nephrosis 1, congenital, Finnish type (nephrin) |
|
multiple interactions |
EXP |
1 |
85,414,492 |
85,444,233 |
RGD:6480464 |
CTD |
| G |
Nphs1 |
nephrosis 1, congenital, Finnish type (nephrin) |
|
multiple interactions |
EXP |
1 |
85,414,492 |
85,444,233 |
RGD:6480464 |
CTD |
| G |
Nphs1 |
nephrosis 1, congenital, Finnish type (nephrin) |
|
decreases expression |
EXP |
1 |
85,414,492 |
85,444,233 |
RGD:6480464 |
CTD |
| G |
Nphs1 |
nephrosis 1, congenital, Finnish type (nephrin) |
|
decreases expression |
EXP |
1 |
85,414,492 |
85,444,233 |
RGD:6480464 |
CTD |
| G |
Nphs1 |
nephrosis 1, congenital, Finnish type (nephrin) |
|
multiple interactions |
EXP |
1 |
85,414,492 |
85,444,233 |
RGD:6480464 |
CTD |
| G |
Nphs1 |
nephrosis 1, congenital, Finnish type (nephrin) |
|
multiple interactions |
EXP |
1 |
85,414,492 |
85,444,233 |
RGD:6480464 |
CTD |
| G |
Nphs1 |
nephrosis 1, congenital, Finnish type (nephrin) |
|
decreases expression |
EXP |
1 |
85,414,492 |
85,444,233 |
RGD:6480464 |
CTD |
| G |
Nphs1 |
nephrosis 1, congenital, Finnish type (nephrin) |
|
decreases expression |
EXP |
1 |
85,414,492 |
85,444,233 |
RGD:6480464 |
CTD |
| G |
Nphs1 |
nephrosis 1, congenital, Finnish type (nephrin) |
|
decreases expression |
EXP |
1 |
85,414,492 |
85,444,233 |
RGD:6480464 |
CTD |
| G |
Nphs2 |
nephrosis 2, idiopathic, steroid-resistant |
|
multiple interactions |
EXP |
13 |
71,296,482 |
71,308,868 |
RGD:6480464 |
CTD |
| G |
Nphs2 |
nephrosis 2, idiopathic, steroid-resistant |
|
decreases expression |
EXP |
13 |
71,296,482 |
71,308,868 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
increases expression |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
increases expression |
ISO |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
multiple interactions |
ISO |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nppb |
natriuretic peptide B |
|
increases expression |
EXP |
5 |
165,062,348 |
165,063,650 |
RGD:6480464 |
CTD |
| G |
Nppc |
natriuretic peptide C |
|
decreases expression |
EXP |
9 |
85,434,254 |
85,438,454 |
RGD:6480464 |
CTD |
| G |
Npy |
neuropeptide Y |
|
multiple interactions |
EXP |
4 |
78,038,013 |
78,045,187 |
RGD:6480464 |
CTD |
| G |
Npy |
neuropeptide Y |
|
increases expression |
EXP |
4 |
78,038,013 |
78,045,187 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
decreases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Ntf3 |
neurotrophin 3 |
|
affects localization |
EXP |
4 |
162,435,781 |
162,506,961 |
RGD:6480464 |
CTD |
| G |
Oat |
ornithine aminotransferase |
|
decreases expression |
EXP |
1 |
192,026,623 |
192,046,404 |
RGD:6480464 |
CTD |
| G |
Oat |
ornithine aminotransferase |
|
multiple interactions |
EXP |
1 |
192,026,623 |
192,046,404 |
RGD:6480464 |
CTD |
| G |
Ogdh |
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
|
multiple interactions |
EXP |
14 |
87,022,994 |
87,090,768 |
RGD:6480464 |
CTD |
| G |
Ogdh |
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
|
increases expression |
EXP |
14 |
87,022,994 |
87,090,768 |
RGD:6480464 |
CTD |
| G |
P2rx2 |
purinergic receptor P2X, ligand-gated ion channel, 2 |
|
increases expression |
ISO |
12 |
46,485,125 |
46,488,319 |
RGD:6480464 |
CTD |
| G |
P2rx3 |
purinergic receptor P2X, ligand-gated ion channel, 3 |
|
increases expression |
ISO |
3 |
68,228,045 |
68,270,751 |
RGD:6480464 |
CTD |
| G |
Pah |
phenylalanine hydroxylase |
|
multiple interactions |
EXP |
7 |
24,175,898 |
24,243,592 |
RGD:6480464 |
CTD |
| G |
Pah |
phenylalanine hydroxylase |
|
increases activity |
EXP |
7 |
24,175,898 |
24,243,592 |
RGD:6480464 |
CTD |
| G |
Pah |
phenylalanine hydroxylase |
|
increases expression |
EXP |
7 |
24,175,898 |
24,243,592 |
RGD:6480464 |
CTD |
| G |
Parg |
poly (ADP-ribose) glycohydrolase |
|
increases response to substance |
ISO |
16 |
7,689,492 |
7,798,104 |
RGD:6480464 |
CTD |
| G |
Pc |
pyruvate carboxylase |
|
increases expression |
EXP |
1 |
207,112,853 |
207,212,737 |
RGD:6480464 |
CTD |
| G |
Pc |
pyruvate carboxylase |
|
multiple interactions |
EXP |
1 |
207,112,853 |
207,212,737 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
increases expression |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
multiple interactions |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
multiple interactions |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
increases expression |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
increases expression |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
multiple interactions |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
increases expression |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pemt |
phosphatidylethanolamine N-methyltransferase |
|
increases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Pemt |
phosphatidylethanolamine N-methyltransferase |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Phb |
prohibitin |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Pik3c2g |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma |
|
multiple interactions |
ISO |
4 |
176,712,201 |
177,074,095 |
RGD:6480464 |
CTD |
| G |
Pik3c2g |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma |
|
decreases expression |
ISO |
4 |
176,712,201 |
177,074,095 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
multiple interactions |
EXP |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
decreases expression |
EXP |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Pkm |
pyruvate kinase, muscle |
|
affects expression |
ISO |
8 |
63,486,492 |
63,508,016 |
RGD:6480464 |
CTD |
| G |
Pmp22 |
peripheral myelin protein 22 |
|
multiple interactions |
EXP |
10 |
49,305,835 |
49,335,864 |
RGD:6480464 |
CTD |
| G |
Pmp22 |
peripheral myelin protein 22 |
|
decreases expression |
EXP |
10 |
49,305,835 |
49,335,864 |
RGD:6480464 |
CTD |
| G |
Pnpt1 |
polyribonucleotide nucleotidyltransferase 1 |
|
affects expression |
ISO |
14 |
110,130,417 |
110,161,762 |
RGD:6480464 |
CTD |
| G |
Polg |
polymerase (DNA directed), gamma |
|
affects expression |
ISO |
1 |
135,197,075 |
135,212,178 |
RGD:6480464 |
CTD |
| G |
Polg2 |
polymerase (DNA directed), gamma 2, accessory subunit |
|
affects expression |
ISO |
10 |
96,120,205 |
96,130,221 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
multiple interactions |
EXP |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
decreases expression |
EXP |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
affects response to substance |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
decreases expression |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
decreases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
decreases expression |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
decreases expression |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
decreases expression |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
multiple interactions |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
multiple interactions |
ISO |
5 |
136,975,780 |
136,991,630 |
RGD:6480464 |
CTD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
decreases expression |
ISO |
5 |
136,975,780 |
136,991,630 |
RGD:6480464 |
CTD |
| G |
Prdx1l1 |
peroxiredoxin 1-like 1 |
|
multiple interactions |
ISO |
2 |
201,373,420 |
201,374,019 |
RGD:6480464 |
CTD |
| G |
Prdx1l1 |
peroxiredoxin 1-like 1 |
|
decreases expression |
ISO |
2 |
201,373,420 |
201,374,019 |
RGD:6480464 |
CTD |
| G |
Prdx2 |
peroxiredoxin 2 |
|
decreases expression |
ISO |
19 |
24,836,199 |
24,841,390 |
RGD:6480464 |
CTD |
| G |
Prdx2 |
peroxiredoxin 2 |
|
multiple interactions |
ISO |
19 |
24,836,199 |
24,841,390 |
RGD:6480464 |
CTD |
| G |
Prdx3 |
peroxiredoxin 3 |
|
multiple interactions |
ISO |
1 |
267,468,371 |
267,481,273 |
RGD:6480464 |
CTD |
| G |
Prdx3 |
peroxiredoxin 3 |
|
decreases expression |
ISO |
1 |
267,468,371 |
267,481,273 |
RGD:6480464 |
CTD |
| G |
Prdx4 |
peroxiredoxin 4 |
|
multiple interactions |
ISO |
X |
61,501,206 |
61,516,286 |
RGD:6480464 |
CTD |
| G |
Prdx4 |
peroxiredoxin 4 |
|
decreases expression |
ISO |
X |
61,501,206 |
61,516,286 |
RGD:6480464 |
CTD |
| G |
Prdx4 |
peroxiredoxin 4 |
|
multiple interactions |
ISO |
X |
61,501,206 |
61,516,286 |
RGD:6480464 |
CTD |
| G |
Prdx5 |
peroxiredoxin 5 |
|
decreases expression |
ISO |
1 |
209,583,414 |
209,586,399 |
RGD:6480464 |
CTD |
| G |
Prdx5 |
peroxiredoxin 5 |
|
multiple interactions |
ISO |
1 |
209,583,414 |
209,586,399 |
RGD:6480464 |
CTD |
| G |
Prdx6 |
peroxiredoxin 6 |
|
multiple interactions |
ISO |
13 |
76,824,968 |
76,835,517 |
RGD:6480464 |
CTD |
| G |
Prdx6 |
peroxiredoxin 6 |
|
decreases expression |
ISO |
13 |
76,824,968 |
76,835,517 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
increases expression |
EXP |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
multiple interactions |
EXP |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Prkcb |
protein kinase C, beta |
|
increases phosphorylation |
EXP |
1 |
181,117,512 |
181,459,856 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
multiple interactions |
EXP |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
multiple interactions |
EXP |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
increases expression |
EXP |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
increases expression |
EXP |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
multiple interactions |
EXP |
6 |
9,631,234 |
10,097,311 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
multiple interactions |
EXP |
6 |
9,631,234 |
10,097,311 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
increases expression |
EXP |
6 |
9,631,234 |
10,097,311 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
increases expression |
EXP |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
multiple interactions |
EXP |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Pygl |
phosphorylase, glycogen, liver |
|
multiple interactions |
EXP |
6 |
92,298,339 |
92,341,347 |
RGD:6480464 |
CTD |
| G |
Pyroxd2 |
pyridine nucleotide-disulphide oxidoreductase domain 2 |
|
increases expression |
EXP |
1 |
248,136,869 |
248,162,250 |
RGD:6480464 |
CTD |
| G |
Pyroxd2 |
pyridine nucleotide-disulphide oxidoreductase domain 2 |
|
multiple interactions |
EXP |
1 |
248,136,869 |
248,162,250 |
RGD:6480464 |
CTD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
multiple interactions |
ISO |
12 |
11,380,314 |
11,400,531 |
RGD:6480464 |
CTD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
multiple interactions |
EXP |
12 |
11,380,314 |
11,400,531 |
RGD:6480464 |
CTD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
increases activity |
EXP |
12 |
11,380,314 |
11,400,531 |
RGD:6480464 |
CTD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
multiple interactions |
EXP |
4 |
151,752,583 |
151,775,609 |
RGD:6480464 |
CTD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
increases expression |
EXP |
4 |
151,752,583 |
151,775,609 |
RGD:6480464 |
CTD |
| G |
Rbp4 |
retinol binding protein 4, plasma |
|
multiple interactions |
EXP |
1 |
242,443,795 |
242,450,997 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases expression |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases expression |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases expression |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases expression |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases expression |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases expression |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rhoa |
ras homolog family member A |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rhoa |
ras homolog family member A |
|
increases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rpl18a |
ribosomal protein L18A |
|
increases expression |
EXP |
16 |
19,042,063 |
19,044,069 |
RGD:6480464 |
CTD |
| G |
Rpl18a |
ribosomal protein L18A |
|
multiple interactions |
EXP |
16 |
19,042,063 |
19,044,069 |
RGD:6480464 |
CTD |
| G |
Rps3 |
ribosomal protein S3 |
|
increases expression |
EXP |
1 |
156,811,470 |
156,816,770 |
RGD:6480464 |
CTD |
| G |
Rps3 |
ribosomal protein S3 |
|
multiple interactions |
EXP |
1 |
156,811,470 |
156,816,770 |
RGD:6480464 |
CTD |
| G |
Rrad |
Ras-related associated with diabetes |
|
increases expression |
EXP |
19 |
272,791 |
275,957 |
RGD:6480464 |
CTD |
| G |
Rrad |
Ras-related associated with diabetes |
|
multiple interactions |
EXP |
19 |
272,791 |
275,957 |
RGD:6480464 |
CTD |
| G |
Ryr2 |
ryanodine receptor 2, cardiac |
|
decreases activity |
EXP |
17 |
68,959,042 |
69,544,816 |
RGD:6480464 |
CTD |
| G |
S100b |
S100 calcium binding protein B |
|
multiple interactions |
EXP |
20 |
12,791,440 |
12,824,508 |
RGD:6480464 |
CTD |
| G |
S100b |
S100 calcium binding protein B |
|
increases expression |
EXP |
20 |
12,791,440 |
12,824,508 |
RGD:6480464 |
CTD |
| G |
S100b |
S100 calcium binding protein B |
|
decreases expression |
EXP |
20 |
12,791,440 |
12,824,508 |
RGD:6480464 |
CTD |
| G |
S100b |
S100 calcium binding protein B |
|
decreases expression |
EXP |
20 |
12,791,440 |
12,824,508 |
RGD:6480464 |
CTD |
| G |
Sdha |
succinate dehydrogenase complex, subunit A, flavoprotein (Fp) |
|
increases expression |
EXP |
1 |
29,739,359 |
29,764,329 |
RGD:6480464 |
CTD |
| G |
Sdha |
succinate dehydrogenase complex, subunit A, flavoprotein (Fp) |
|
multiple interactions |
EXP |
1 |
29,739,359 |
29,764,329 |
RGD:6480464 |
CTD |
| G |
Sdhb |
succinate dehydrogenase complex, subunit B, iron sulfur (Ip) |
|
multiple interactions |
EXP |
5 |
159,818,669 |
159,839,772 |
RGD:6480464 |
CTD |
| G |
Sdhb |
succinate dehydrogenase complex, subunit B, iron sulfur (Ip) |
|
increases expression |
EXP |
5 |
159,818,669 |
159,839,772 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
multiple interactions |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression |
EXP |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
multiple interactions |
EXP |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
multiple interactions |
EXP |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression |
EXP |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpinh1 |
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) |
|
increases expression |
EXP |
1 |
156,666,914 |
156,674,210 |
RGD:6480464 |
CTD |
| G |
Sfxn1 |
sideroflexin 1 |
|
multiple interactions |
EXP |
17 |
16,601,066 |
16,636,502 |
RGD:6480464 |
CTD |
| G |
Sfxn1 |
sideroflexin 1 |
|
increases expression |
EXP |
17 |
16,601,066 |
16,636,502 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
increases expression |
ISO |
1 |
23,501,257 |
23,506,651 |
RGD:6480464 |
CTD |
| G |
Sgk2 |
serum/glucocorticoid regulated kinase 2 |
|
increases expression |
ISO |
3 |
153,849,825 |
153,890,111 |
RGD:6480464 |
CTD |
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
multiple interactions |
EXP |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
decreases expression |
EXP |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc25a10 |
solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10 |
|
increases expression |
EXP |
10 |
109,877,811 |
109,885,272 |
RGD:6480464 |
CTD |
| G |
Slc25a26 |
solute carrier family 25 (S-adenosylmethionine carrier), member 26 |
|
affects expression |
ISO |
4 |
128,822,640 |
128,917,832 |
RGD:6480464 |
CTD |
| G |
Slc25a3 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 3 |
|
increases expression |
EXP |
7 |
28,054,665 |
28,061,801 |
RGD:6480464 |
CTD |
| G |
Slc25a3 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 3 |
|
multiple interactions |
EXP |
7 |
28,054,665 |
28,061,801 |
RGD:6480464 |
CTD |
| G |
Slc25a4 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
|
multiple interactions |
ISO |
16 |
49,353,476 |
49,357,271 |
RGD:6480464 |
CTD |
| G |
Slc25a47 |
solute carrier family 25, member 47 |
|
affects expression |
ISO |
6 |
133,192,144 |
133,197,778 |
RGD:6480464 |
CTD |
| G |
Slc27a1 |
solute carrier family 27 (fatty acid transporter), member 1 |
|
increases expression |
EXP |
16 |
18,769,909 |
18,786,988 |
RGD:6480464 |
CTD |
| G |
Slc27a1 |
solute carrier family 27 (fatty acid transporter), member 1 |
|
multiple interactions |
EXP |
16 |
18,769,909 |
18,786,988 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
increases response to substance |
EXP |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
decreases expression |
ISO |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
multiple interactions |
ISO |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
multiple interactions |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
multiple interactions |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
affects expression |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
decreases expression |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
decreases expression |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
multiple interactions |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
multiple interactions |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
multiple interactions |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
multiple interactions |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
affects localization |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
decreases expression |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
decreases expression |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
multiple interactions |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
decreases expression |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
decreases expression |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
decreases expression |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
multiple interactions |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
decreases expression |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc3a1 |
solute carrier family 3, member 1 |
|
decreases expression |
EXP |
6 |
8,385,186 |
8,419,465 |
RGD:6480464 |
CTD |
| G |
Slc3a1 |
solute carrier family 3, member 1 |
|
multiple interactions |
EXP |
6 |
8,385,186 |
8,419,465 |
RGD:6480464 |
CTD |
| G |
Smad2 |
SMAD family member 2 |
|
increases phosphorylation |
EXP |
18 |
73,180,520 |
73,241,707 |
RGD:6480464 |
CTD |
| G |
Smad2 |
SMAD family member 2 |
|
multiple interactions |
EXP |
18 |
73,180,520 |
73,241,707 |
RGD:6480464 |
CTD |
| G |
Smad3 |
SMAD family member 3 |
|
multiple interactions |
EXP |
8 |
67,803,909 |
67,952,056 |
RGD:6480464 |
CTD |
| G |
Smad3 |
SMAD family member 3 |
|
increases phosphorylation |
EXP |
8 |
67,803,909 |
67,952,056 |
RGD:6480464 |
CTD |
| G |
Smad4 |
SMAD family member 4 |
|
increases expression |
EXP |
18 |
70,432,705 |
70,461,541 |
RGD:6480464 |
CTD |
| G |
Smad4 |
SMAD family member 4 |
|
increases expression |
EXP |
18 |
70,432,705 |
70,461,541 |
RGD:6480464 |
CTD |
| G |
Smad4 |
SMAD family member 4 |
|
multiple interactions |
EXP |
18 |
70,432,705 |
70,461,541 |
RGD:6480464 |
CTD |
| G |
Smad4 |
SMAD family member 4 |
|
increases expression |
EXP |
18 |
70,432,705 |
70,461,541 |
RGD:6480464 |
CTD |
| G |
Smad6 |
SMAD family member 6 |
|
increases expression |
EXP |
8 |
68,144,395 |
68,214,652 |
RGD:6480464 |
CTD |
| G |
Smad7 |
SMAD family member 7 |
|
affects expression |
EXP |
18 |
72,294,803 |
72,323,354 |
RGD:6480464 |
CTD |
| G |
Sncg |
synuclein, gamma (breast cancer-specific protein 1) |
|
increases expression |
EXP |
16 |
10,025,978 |
10,030,516 |
RGD:6480464 |
CTD |
| G |
Sncg |
synuclein, gamma (breast cancer-specific protein 1) |
|
multiple interactions |
EXP |
16 |
10,025,978 |
10,030,516 |
RGD:6480464 |
CTD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
decreases expression |
EXP |
10 |
107,958,468 |
107,959,330 |
RGD:6480464 |
CTD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
multiple interactions |
EXP |
10 |
107,958,468 |
107,959,330 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
affects expression |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases expression |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
decreases activity |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
decreases expression |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod3 |
superoxide dismutase 3, extracellular |
|
decreases expression |
EXP |
14 |
63,381,447 |
63,387,180 |
RGD:6480464 |
CTD |
| G |
Sod3 |
superoxide dismutase 3, extracellular |
|
multiple interactions |
EXP |
14 |
63,381,447 |
63,387,180 |
RGD:6480464 |
CTD |
| G |
Sord |
sorbitol dehydrogenase |
|
multiple interactions |
EXP |
3 |
109,016,830 |
109,048,446 |
RGD:6480464 |
CTD |
| G |
Sord |
sorbitol dehydrogenase |
|
increases expression |
EXP |
3 |
109,016,830 |
109,048,446 |
RGD:6480464 |
CTD |
| G |
Sord |
sorbitol dehydrogenase |
|
increases glycation |
EXP |
3 |
109,016,830 |
109,048,446 |
RGD:6480464 |
CTD |
| G |
Sparc |
secreted protein, acidic, cysteine-rich (osteonectin) |
|
increases expression |
ISO |
10 |
40,809,730 |
40,831,481 |
RGD:6480464 |
CTD |
| G |
Sphk1 |
sphingosine kinase 1 |
|
increases expression |
ISO |
10 |
106,641,509 |
106,645,579 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
|
increases expression |
EXP |
4 |
105,373,385 |
105,432,192 |
RGD:6480464 |
CTD |
| G |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
|
multiple interactions |
EXP |
4 |
105,373,385 |
105,432,192 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
EXP |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
increases phosphorylation |
EXP |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
EXP |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
EXP |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
increases expression |
EXP |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
increases phosphorylation |
EXP |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
increases phosphorylation |
EXP |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Sucla2 |
succinate-CoA ligase, ADP-forming, beta subunit |
|
affects expression |
ISO |
15 |
54,214,262 |
54,267,830 |
RGD:6480464 |
CTD |
| G |
Syp |
synaptophysin |
|
increases expression |
ISO |
X |
26,890,307 |
26,905,319 |
RGD:6480464 |
CTD |
| G |
Syp |
synaptophysin |
|
multiple interactions |
ISO |
X |
26,890,307 |
26,905,319 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
multiple interactions |
EXP |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
multiple interactions |
EXP |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
decreases expression |
EXP |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
multiple interactions |
EXP |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
increases expression |
EXP |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
decreases secretion |
EXP |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tek |
TEK tyrosine kinase, endothelial |
|
increases expression |
EXP |
5 |
115,047,195 |
115,196,172 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases secretion |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
decreases expression |
ISO |
8 |
120,593,595 |
120,680,453 |
RGD:6480464 |
CTD |
| G |
Thbs1 |
thrombospondin 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Thbs1 |
thrombospondin 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Thbs1 |
thrombospondin 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Thbs4 |
thrombospondin 4 |
|
multiple interactions |
EXP |
2 |
23,010,823 |
23,053,527 |
RGD:6480464 |
CTD |
| G |
Thbs4 |
thrombospondin 4 |
|
increases expression |
EXP |
2 |
23,010,823 |
23,053,527 |
RGD:6480464 |
CTD |
| G |
Thrsp |
thyroid hormone responsive |
|
multiple interactions |
EXP |
1 |
154,647,339 |
154,651,663 |
RGD:6480464 |
CTD |
| G |
Thrsp |
thyroid hormone responsive |
|
decreases expression |
EXP |
1 |
154,647,339 |
154,651,663 |
RGD:6480464 |
CTD |
| G |
Timm8b |
translocase of inner mitochondrial membrane 8 homolog b (yeast) |
|
affects expression |
ISO |
8 |
53,964,693 |
53,966,073 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
increases expression |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Tinag |
tubulointerstitial nephritis antigen |
|
increases expression |
EXP |
8 |
81,947,234 |
82,032,994 |
RGD:6480464 |
CTD |
| G |
Tinag |
tubulointerstitial nephritis antigen |
|
multiple interactions |
EXP |
8 |
81,947,234 |
82,032,994 |
RGD:6480464 |
CTD |
| G |
Tlr3 |
toll-like receptor 3 |
|
multiple interactions |
ISO |
16 |
50,112,910 |
50,126,371 |
RGD:6480464 |
CTD |
| G |
Tlr3 |
toll-like receptor 3 |
|
increases expression |
ISO |
16 |
50,112,910 |
50,126,371 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
multiple interactions |
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
increases expression |
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
|
multiple interactions |
ISO |
5 |
163,666,541 |
163,697,484 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
|
increases expression |
ISO |
5 |
163,666,541 |
163,697,484 |
RGD:6480464 |
CTD |
| G |
Tomm40 |
translocase of outer mitochondrial membrane 40 homolog (yeast) |
|
affects expression |
ISO |
1 |
79,008,895 |
79,020,420 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Trh |
thyrotropin releasing hormone |
|
decreases expression |
EXP |
4 |
126,425,212 |
126,427,670 |
RGD:6480464 |
CTD |
| G |
Trh |
thyrotropin releasing hormone |
|
multiple interactions |
EXP |
4 |
126,425,212 |
126,427,670 |
RGD:6480464 |
CTD |
| G |
Trpv4 |
transient receptor potential cation channel, subfamily V, member 4 |
|
increases response to substance |
EXP |
12 |
43,226,933 |
43,265,889 |
RGD:6480464 |
CTD |
| G |
Ttr |
transthyretin |
|
decreases expression |
EXP |
18 |
12,406,571 |
12,413,680 |
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
multiple interactions |
ISO |
5 |
75,921,365 |
75,933,595 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
increases expression |
ISO |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
increases expression |
EXP |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
increases expression |
ISO |
1 |
157,896,001 |
157,909,608 |
RGD:6480464 |
CTD |
| G |
Uox |
urate oxidase |
|
affects expression |
ISO |
2 |
244,795,552 |
244,832,143 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
EXP |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
EXP |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
increases expression |
EXP |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
increases expression |
EXP |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
EXP |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
increases expression |
EXP |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
increases expression |
EXP |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
EXP |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
increases expression |
EXP |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vdac1 |
voltage-dependent anion channel 1 |
|
increases expression |
EXP |
10 |
37,795,721 |
37,823,253 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
multiple interactions |
EXP |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
increases expression |
EXP |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
increases expression |
EXP |
X |
3,011,520 |
3,047,798 |
RGD:6480464 |
CTD |
Term paths to the root
|